Trial intelligence / Profile preview

Bryostatin-1 and Cisplatin in Advanced Cervical Cancer

NCT00005965Phase 2Completed

Sponsor
Icahn School of Medicine at Mount Sinai
Start
Aug 2000
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of bryostatin-1 in Cervical Cancer (CC), sponsored by Icahn School of Medicine at Mount Sinai. Started Aug 2000; status: completed.

02

Drugs

bryostatin-1
03

Conditions

Cervical Cancer (CC)

Beyond the preview

Go deeper on NCT00005965.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00005965.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call